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Title: Patient experiences of treatment for diabetic retinopathy: development of a 
retinopathy-specific treatment satisfaction questionnaire. 
Aims: To design a measure of satisfaction with treatments for diabetic retinopathy, 
incorporating patient views. 
Methods: An iterative approach incorporated qualitative and quantitative methods. In 
44 semi-structured interviews (11 in each of 2 UK and 2 German hospitals) 
respondents described experiences of retinopathy treatments and reactions to 
possible new treatments. They completed and commented on the latest draft 
Retinopathy Treatment Satisfaction Questionnaire (RetTSQ), which was revised and 
translated between centres to incorporate patient views. Interviews were content 
analysed.  
Interviewees:  44 people with varying levels of diabetic retinopathy, 31 having 
macular oedema.  26 men, 18 women. Median age 60.8 (range: 28-82); median 
visual acuity best eye 0.80 (range: detect hand motion at 1 metre (0.0025) – 6/5 
vision (1.20). Laser photocoagulation sessions ranged 0-20; vitrectomies ranged 0-2.  
Results: Dimensions of satisfaction were similar in UK and Germany and included 
satisfaction with treatment effectiveness, emotional and physical experiences 
(before, during and after treatment), information provision and influence over 
treatment. Content and layout of the resulting 13-item RetTSQ are appropriate for 
people with diabetic retinopathy. 
Conclusions: There is considerable scope for improving patient experience of 
diabetic retinopathy treatments. The RetTSQ will be useful in evaluating current and 
future treatments in research and clinical contexts. 
 
